GlassScriptPhysician profile
Melissa W Hoercher
NPI 1730117136
$2,554.08
in general payments reported to CMS, 2019-2025
16 companies · $511 in 2025
The $511 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $156 · 2021: $413 · 2022: $519 · 2023: $393 · 2024: $303 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.89 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $416.59 | 2023-2025 | Syfovre |
| Alcon Vision LLC | $331.83 | 2020-2024 | Total30 |
| Bausch & Lomb Americas INC. | $321.21 | 2023-2025 | Miebo, Xiidra, Infuse |
| Allergan, INC. | $218.21 | 2021-2022 | |
| Dompe US, INC. | $192.38 | 2023-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $134.94 | 2024-2025 | Xdemvy |
| Optos, INC. | $134.07 | 2019 | |
| Sun Pharmaceutical Industries INC. | $127.67 | 2020-2024 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Aerie Pharmaceuticals, INC. | $120.54 | 2021 | |
| Glaukos Corporation | $80.35 | 2020 | |
| Abbvie INC. | $78.10 | 2022 | |
| Harrow Eye, LLC | $54.81 | 2025 | Vevye |
| Sight Sciences, INC. | $48.58 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $44.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Hoercher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.